Tau Degrader for Alzheimer’s & Primary Tauopathies: From Platform Development to Translation
Time: 3:15 pm
day: Conference Day Two
Details:
- Overview of misfolded protein aggregates for targeted protein degradation
- Review of technologies and pathways being pursued for tau degrader drug development
- Future directions of translating tau degrader to drug in clinics
